Chief Executive Officer
Mr. Wagner has more than 25 years of experience in marketing pharmaceutical products and building biotechnology companies. He most recently served as Chairman, President and CEO of Contextual Genomics Inc., a molecular bioinformatics company that has worked with AstraZeneca, Pfizer and Sanofi to develop genomic cancer diagnostic products. Prior to that, Mr. Wagner served as Vice President, Business Development and Global Marketing at Aspreva Pharmaceuticals Inc. Before Aspreva, he worked at Eli Lilly, rising to Global Team Leader and helping to develop and commercialize 15 biologic and small molecule products. Mr. Wagner has a BSc in organic chemistry from the University of British Columbia and completed executive programs in finance and marketing research at Wharton Business School and Kellogg School of Management.
Chief Financial Officer
Mr. Hill has more than 20 years of accounting, finance and senior leadership experience. He is a seasoned manager of private and publicly traded technology and financial services businesses in Canada, USA, and Asia. Prior to joining Emerald, Mr. Hill was the Chief Financial Officer of Tokyo-based Minkabu, a technology company advancing sophisticated stock market intelligence and financial data solutions. Before that, he held financial leadership positions at Haywood Securities in Vancouver, Vignette Corp. and Trilogy Software in Austin, TX. Mr. Hill earned a BSc from the University of British Columbia and his certification from the Chartered Professional Accountants of British Columbia, Canada while articling with KPMG LLP.
Executive Vice President of Global Sales and Marketing
Mr. Dillman has more than 30 years of experience in global marketing, sales and general management for leading consumer brands. As Deputy Group Marketing Director at Coca-Cola, he was responsible for marketing and sales from Korea to Indonesia and leading Centers of Excellence across the region. Mr. Dillman later served as the VP Marketing & Sales, Central & Eastern Europe at AB InBev, where he successfully implemented controlled marketing efforts that exceeded revenue targets of $1.9 billion. Additionally, as the VP of Global Brands, he was responsible for the global marketing campaigns of popular beer brands including; Beck’s, Bass, Staropramen, Leffe, and Hoegaarden. Prior to that, Mr. Dillman served Philip Morris International as Area Director, with responsibility for managing more than 425 employees in packaging and licensing. Before Philip Morris, he worked with Kraft Foods, serving as Director of Strategic Planning and later General Manager of Kraft Korea. Mr. Dillman earned a BSc from West Point (United States Military Academy) and a master’s in systems management from the University of Southern California.
Vice President, Research
Dr. Garabagi is a research scientist and inventor in the fields of plant molecular genetics and medical biotechnology. He has 10 years of experience conducting postdoctoral research at the University of Guelph, where he developed intellectual property (IP) on the production of plant-derived Herceptin, a therapeutic monoclonal antibody used in the treatment of breast cancer. Dr. Garabagi also has extensive experience in the development of DNA-based techniques for improving insect pest management strategies. A member of the International Association for Plant Biotechnology and the Canadian Society of Plant Biologists, he has published numerous scientific papers and books relating to plants. Dr. Garabagi holds a PhD in molecular genetics from the University of Guelph.
Vice President, Operations
Mr. Bierman has more than 25 years of experience in manufacturing management, product development, and marketing; from commodity products to fast moving consumer goods. Prior to joining Emerald, Mr. Bierman was the divisional controller for Tolko Industries and then served as the general manager of Lighthouse Brewing Company. Mr. Bierman earned a diploma in accounting and is a certified management accountant.
Vice President, Quality Affairs
Ms. Wong has more than 25 years of managerial experience in quality assurance and quality control spanning preclinical, clinical, and commercial phases for pharmaceuticals, genetically engineered products and medical devices. Before joining Emerald, she was the Executive Director of Quality Assurance at Novelion Therapeutics (formerly QLT Inc.), where she led the strategy for quality assurance, equipment validation, compliance auditing, document management, and GxP training. Ms. Wong previously worked for life science companies including MDS Nordion, Cangene Corporation, and Biomira Inc. Specializing in microbiology, she earned a BSc from the University of Alberta.
Vice President, Production
Mr. Graham is the Master Grower for Emerald Health Botanicals, responsible for the medical cannabis growing facility in Victoria, BC and all of the company’s plant production. He has been producing medical cannabis since the inception of the MMAR (Marihuana Medical Access Regulations) program in 2001. His experience encompasses all aspects of production, including large and small plant types, soil and hydroponic environments, and indoor and outdoor greenhouse enclosures. Mr. Graham has for several years been a professional consultant in cannabis production and grow room design.